October 14, 2025
“Citigroup posted stronger-than-expected third-quarter earnings on Tuesday before the bell, with every division generating record revenue. Here’s what the bank reported compared with what Wall Street was expecting, based on a survey of analysts by LSEG: Shares of the bank dipped… Continue Reading…
October 8, 2024
“Stellantis reported U.S. sales Wednesday of 305,294 from July through September, a 19.8% decline from the third quarter of 2023. The company was expected to be the worst sales performer of major automakers during the third quarter. Stellantis’ disappointing sales… Continue Reading…
August 2, 2024
“Boeing reported a bigger loss and weaker revenue than analysts expected for the second quarter. Both the company’s commercial and defense units have been challenged by programs running behind schedule and higher-than-expected costs. The company is under increased federal scrutiny… Continue Reading…
December 8, 2023
“U.S. household wealth fell to roughly $151 trillion in the third quarter, pulled down by a drop in the value of stocks which more than offset a half-trillion rise in the value of property prices, the Federal Reserve said on… Continue Reading…
November 10, 2023
“China’s largest chipmaker SMIC on Thursday posted a 80% drop in third-quarter profit as global demand weakness hit foundries hard. Net income for the quarter ended September plunged 80% compared to a year ago — larger than the 64% drop posted in second quarter… Continue Reading…
November 3, 2023
“…Shares of Palantir closed up 20% Thursday after the company released third-quarter earnings that beat analysts’ expectations and raised full-year revenue guidance. Here’s how the company did: Palantir’s revenue for the third quarter increased 17% to $558 million, from $478 million a year earlier.… Continue Reading…
November 2, 2023
“…Mounjaro, Lilly’s new diabetes drug, brought in $1.41 billion in sales, growing 652% and coming in above estimates for $1.28 billion. Lilly is hoping the Food and Drug Administration will soon approve Mounjaro as a weight-loss drug…” https://www.investors.com/news/technology/eli-lilly-stock-eli-lilly-earnings-q3-2023/?src=A00220
October 26, 2023
“…Gross domestic product, a measure of all goods and services produced in the U.S., rose at a 4.9% annualized pace in the July-through-September period, up from an unrevised 2.1% pace in the second quarter, the Commerce Department reported Thursday.. Economists surveyed by… Continue Reading…
Recent Comments